Apellis Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Apellis Pharmaceuticals, Inc.
CIK #0001492422
EDGAR Form CIK 2011 - 2024
10-K [0001492422]
10-Q [0001492422]
3 [0001492422]
4 [0001492422]
5 [0001492422]
8-K [0001492422]
D [0001492422]
SC 13G [0001492422]
Form 13D/13G Filer Form 13D/13G Subject Filed
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2024-02-14]
EcoR1 Capital LLC Apellis Pharmaceuticals Inc [2023-07-18]
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2023-02-14]
Price T Rowe Associates Inc /MD/ Apellis Pharmaceuticals Inc [2022-02-14]
Avoro Capital Advisors LLC Apellis Pharmaceuticals Inc [2022-02-11]
Vanguard Group Inc Apellis Pharmaceuticals Inc [2021-02-10]
Wellington Management Group LLP Apellis Pharmaceuticals Inc [2020-01-28]
Morningside Venture Investments Ltd Apellis Pharmaceuticals Inc [2019-02-14]
BlackRock Inc Apellis Pharmaceuticals Inc [2019-02-08]
Morningside Venture Investments Ltd Apellis Pharmaceuticals Inc [2018-02-14]
View All
Form 3/4/5 Subject 2011 - 2024
Apellis Pharmaceuticals, Inc.
Watson David O.
Dunlop A. Sinclair
Chopas James George
DeLong Mark Jeffrey
Deschatelets Pascal
Sullivan Timothy Eugene
Nicholson Nur
Francois Cedric
Townsend Adam J.
View All
Terms | Privacy | Guide
tony@aum13f.com